Doylestown, Pennsylvania, August 16, 2021 / PRNewswire /-AssisTek, a boutique eSource company known for providing customized solutions to support clinical trial teams for 25 years, California Medical technology companies will integrate ECG / EKG capabilities into the eSource platform for clinical trials.
This latest technology integration extends assisTek’s eCOA products by enabling real-time collection and review of ECG / EKG data on any eCOA device, including tablets and smartphones. It also reduces patient burden, increases safety, and improves data quality and flow.
Integration is the first of its kind.
“IMedrix’s Kardio Screen is an FDA-approved, innovative mobile, cloud-connected ECG / EKG device that simplifies the cardiac monitoring process in a variety of settings,” he said. Cindy Howley, President of assisTek. “In the context of clinical trials, it allows us to enable the complete steps of the process. In short, it’s a perfect addition to our ever-growing list of abilities.”
Srikanth (Sree) Jadcherla, founder and CEO of iMedrix, said the partnership was “an ideal entry for iMedrix to enter decentralized clinical trials for US pharmaceutical companies, and iMedrix has been with pharmaceutical companies. It constitutes the continuation of the project. ” Asia, Europe, When Africa.. “
assisTek has created a video showing how the integration of KardioScreen and the assisTek eCOA platform can help patients, healthcare providers, and clinical researchers.
assisTek provides field-based and site-based electronic data capture solutions for clinical outcome assessment, including Patient Reported Outcomes (PRO), Clinician Reported Outcomes (ClinROs), Observer Reported Outcomes (ObsROs), and Performance Outcomes (ObsROs). It is a company. PerfOs). The company offers solutions for more than 500 clinical trials, supporting 90 different languages ​​in 80 countries, and has experience in 46 therapeutic areas, including rare and ultra-rare diseases.
iMedrix provides state-of-the-art medical technology through the Kardio Screen, a fully mobile 12/6 lead FDA-approved electrocardiogram (ECG or EKG). iMedrix provides a direct diagnostic solution to EMR systems and produces clinical grade ECG traces with device accuracy proven by over 200,000 ECGs worldwide. iMedrix uses artificial intelligence (AI), cloud technology, and machine learning (ML) to revolutionize heart health management, enabling rapid diagnostics and accurate clinical decisions. (1-866-IMEDRIX)
Vice President of Commerce
assisTek Announces Collaboration with Mobile ECG / EKG Technology | State
Source link assisTek Announces Collaboration with Mobile ECG / EKG Technology | State


Por redditxxx